Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, PagodaTree Partners is a private equity fund manager based in China, specializing in healthcare and technology innovation. The firm has been named one of the 'Top 10 Emerging Venture Capital Institutions' in China in 2022 and listed among the 'Top 50 Best VC Funds' in 2023. Its core management team brings extensive experience from international investment institutions, particularly in healthcare and cross-border mergers and acquisitions.
PagodaTree Partners invests in the healthcare and life sciences sectors, as well as technology innovation and related interdisciplinary fields. The firm engages in pre-seed, seed, seed+, and growth equity investments, actively seeking special opportunities and collaborating closely with entrepreneurs to create value.
Yes, PagodaTree Partners often leads investment rounds, particularly in early-stage and growth-stage opportunities within its focus sectors.
The firm is open to follow-on investments, especially for companies that align with its investment thesis in healthcare and technology innovation.
Specific fund size details are not disclosed, but the firm is recognized among the top VC funds in China, indicating a significant capital base.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.